Loading stock data…
ULBI
$6.86-0.04 (-0.58%)
Market ClosedLast close May 1
Ultralife Corporation, together with its subsidiaries, designs, manufactures, installs, and maintains power, and communication and electronics systems worldwide.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Ultralife Corporation in the Industrials sector is trading at $6.86. The stock is currently 28% below its 52-week high of $9.52, remaining 3.9% above its 200-day moving average. Technical signals show neutral RSI of 47 and bearish MACD signal, explaining why ULBI maintains its current momentum and trend strength. The Whystock Score of 75/100 reflects a high-conviction bullish alignment.
Ecosystem Influences
Neutral momentum (RSI 47) — price action in range
Long-term trend bullish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$6.86
Potential Upside
5%
Whystock Fair Value$7.20
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Fundamentals
Ultralife Corporation, together with its subsidiaries, designs, manufactures, installs, and maintains power, and communication and electronics systems worldwide. The company operates in two segments, Battery & Energy Products and Communications Syste...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$127.42M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
Defensive asset. Lower volatility than the S&P 500.
0.72
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-4.54%
Volume
Today's trading volume
14,031
Recent News
Ultralife Corp (ULBI) Q4 2025 Earnings Call Highlights: Revenue Growth Amidst Challenges
Ultralife Corp (ULBI) reports strong revenue growth but faces profitability challenges due to non-cash impairments and communication segment declines.
Ultralife Q4 Earnings Call Highlights
Ultralife (NASDAQ:ULBI) reported fourth-quarter fiscal 2025 revenue of $48.5 million, up 10.6% from the prior-year period, as strength in its battery and energy products business more than offset a decline in Communications Systems sales. Management also highlighted a year-end backlog of $110.2 mill
Ultralife: Q4 Earnings Snapshot
The Newark, New York-based company said it had a loss of 45 cents per share. Earnings, adjusted for asset impairment costs, were 12 cents per share. The power and communications systems maker posted revenue of $48.5 million in the period.
With 40% ownership, insiders at Ultralife Corporation (NASDAQ:ULBI) are pretty optimistic and have been buying recently
Key Insights Significant insider control over Ultralife implies vested interests in company growth The top 3...
Ultralife Corp (ULBI) Q3 2025 Earnings Call Highlights: Revenue Growth Amid Operational Challenges
Ultralife Corp (ULBI) reports a 21.5% revenue increase despite facing a net loss and operational inefficiencies in Q3 2025.